Login
$CUE
$18.45 -$0.21 (1.13%) Close

Insider Transactions

What Cue Biopharma, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 5
Sells 15 15
Total trades 19 33

Shares traded

3 months 12 months
Acquired 166,522 729,132
Disposed 86,790 86,790
Net activity +79,732 +642,342

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Ray Sumita Chief Legal Compliance Officer Oct 12 Open-market sale · S −1,844 $28.05 −$51.7K 116,701
Meluzio Michael Vincent VP, Prin. Accounting Officer Oct 12 Open-market sale · S −1,144 $28.05 −$32.1K 47,817
Lin Shao-Lee Chief Executive Officer Oct 12 Open-market sale · S −1,087 $28.05 −$30.5K 694,908
Lin Shao-Lee Chief Executive Officer Oct 12 Open-market sale · S −10,000 $27.50 −$275K 695,995
Lin Shao-Lee Chief Executive Officer Aug 13 Open-market sale · S −10,460 $29.48 −$308K 705,995
Lin Shao-Lee Chief Executive Officer Aug 13 Open-market sale · S −2,375 $28.11 −$66.8K 716,455
Lin Shao-Lee Chief Executive Officer Aug 13 Open-market sale · S −5,423 $27.19 −$147K 718,830
Ray Sumita Chief Legal Compliance Officer Aug 13 Open-market sale · S −4 $31.13 −$125 118,545
Ray Sumita Chief Legal Compliance Officer Aug 13 Open-market sale · S −6,442 $30.35 −$196K 118,549
Ray Sumita Chief Legal Compliance Officer Aug 13 Open-market sale · S −2,383 $29.37 −$70K 124,991
Ray Sumita Chief Legal Compliance Officer Aug 13 Exercise / conversion · M +18,196 — — 127,374
Meluzio Michael Vincent VP, Prin. Accounting Officer Aug 13 Open-market sale · S −3 $31.13 −$93.4 48,961
Meluzio Michael Vincent VP, Prin. Accounting Officer Aug 13 Open-market sale · S −4,106 $30.35 −$125K 48,964
Meluzio Michael Vincent VP, Prin. Accounting Officer Aug 13 Open-market sale · S −1,519 $29.37 −$44.6K 53,070
Meluzio Michael Vincent VP, Prin. Accounting Officer Aug 13 Exercise / conversion · M +13,647 — — 54,589
Lin Shao-Lee Chief Executive Officer Aug 12 Open-market sale · S −5,775 $27.75 −$160K 724,253
Lin Shao-Lee Chief Executive Officer Aug 12 Open-market sale · S −34,225 $26.99 −$924K 730,028
Lin Shao-Lee Chief Executive Officer Aug 12 Exercise / conversion · M +109,179 — — 764,253
Ahlers James M Chief Financial Officer Jul 30 Grant / award · A +25,500 — — 25,500
Borie Dominique Christian Chief Medical Officer Jul 13 Grant / award · A +31,500 — — 31,500

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support